Literature DB >> 25063055

Copeptin as a diagnostic biomarker for sepsis-related deaths.

Cristian Palmiere1, Marc Augsburger2.   

Abstract

Copeptin has been shown to increase in patients with sepsis, severe sepsis and septic shock. In the study herein described, copeptin was measured in a series of sepsis-related fatalities and control cases that underwent medico-legal investigations. No age-dependent differences in copeptin levels in either sepsis or control cases were observed. No correlation between copeptin concentrations and postmortem interval was identified in either group. Copeptin levels were significantly higher in sepsis cases. Moreover, copeptin concentrations in septic cases correlated with procalcitonin, C-reactive protein and interleukin 6 values. These preliminary findings seem to indicate that copeptin can be reliably measured in biological samples collected during postmortem investigations. These results also suggest that hemodynamic instability associated with sepsis and septic shock can be characterized by copeptin measurement also in the forensic casework.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autopsy; Copeptin; Postmortem biochemistry; Sepsis

Mesh:

Substances:

Year:  2014        PMID: 25063055     DOI: 10.1016/j.peptides.2014.07.011

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

Review 1.  Endocrine dysfunction in sepsis: a beneficial or deleterious host response?

Authors:  Valeriu Gheorghiţă; Alina Elena Barbu; Monica Livia Gheorghiu; Florin Alexandru Căruntu
Journal:  Germs       Date:  2015-03-02

2.  Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS).

Authors:  Kyeongman Jeon; Jae-Uk Song; Chi Ryang Chung; Jeong Hoon Yang; Gee Young Suh
Journal:  Crit Care       Date:  2018-05-21       Impact factor: 9.097

3.  Risk assessment of sepsis through measurement of proAVP (copeptin): a secondary analysis of the TRIAGE study.

Authors:  Milena Kloter; Claudia Gregoriano; Ellen Haag; Alexander Kutz; Beat Mueller; Philipp Schuetz
Journal:  Endocr Connect       Date:  2021-08-24       Impact factor: 3.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.